RESEARCH ARTICLE. Incidence and Associated Risk Factors of LV Clot Among Patients with Myocardial Infarction of Urmia Seyyed-O- Shohada Heart Center

Size: px
Start display at page:

Download "RESEARCH ARTICLE. Incidence and Associated Risk Factors of LV Clot Among Patients with Myocardial Infarction of Urmia Seyyed-O- Shohada Heart Center"

Transcription

1 ISSN Journal of Global Pharma Technology Available Online at RESEARCH ARTICLE Incidence and Associated Risk Factors of LV Clot Among Patients with Myocardial Infarction of Urmia Seyyed-O- Shohada Heart Center Kamal Khademvatani 1, Alireza Rostamzadeh 2*, Mir Hosein Seyyed Mohammadzad 2, Mohammad Reza Rajabi 3 1 Associated Professor of Cardiology, University of Medical Sciences, Urmia, Iran. 2 Assistant Professor of Cardiology, University of Medical Sciences, Urmia, Iran. 2 Student Cardiology, Urmia University of Medical Sciences, Urmia, Iran. *Corresponding Author : Alireza Rostamzadeh Abstract Background Based on previous experiments with a limited number of samples, it seems that the use of anticoagulants (heparin or subcutaneous high dose heparin) reduces by % 50of the progression of left ventricular embolism. In this study, we determined to investigate the incidence and factors associated with left ventricular in patients with acute myocardial infarction admitted to S eyyed alshohada University Hospital. Methods: In this analytic cohort study, patients with myocardial infarction were included and risk factors of LV clot following of myocardial infarction as, diabetes mellitus, smoking, hypertension, dyslipidemia, higher age, gender, extent of cardiac involvement, LV diastolic dysfunction and reperfusion were evaluated. Also, other echocardiography parameters as LV size, LV systolic and diastolic dysfunction, assessed and recorded in a check list. Finally effect of each factor on incidence of LV clot was evaluated separately. Results In our study, we found no significant association between underlying disease, diabetes, history of prior MI, history of hyperlipidemia, smoking and SK infusion, but there was a significant association between the type of MI and clots in the left ventricle. In this study, we found no significant association between the incidence of within the left ventricle and Primary PCI. Also receiving Heparin and/or Enoxaparin and Metoral are not significantly associated with LV clots. However, there is no significant association between LV size and count of involved leads in the incidence of left ventricular. Conclusion Finally, according to the results of the study it can be said that the time from onset of the pain until revascularization in the hospital, had an important role in preventing LV clots and the outcomes of the patient. Keywords: Incidence, Risk factors, LV clot, Myocardial infarction. Introduction Myocardial infarction occurs following clot on a wound atherosclerotic plaque. These clots following a complete blockage of blood vessels prevent blood containing oxygen and nutrients to reach the tissues, the blocked blood vessels are responsible for blood supply to the area. According to WHO and AHA, myocardial infarction is known through 2 out of 3 of the following include chest pain indicate heart (pressing pain for more than half an hour), certain changes in ECG of the patient (with a minimum 1 mm ST segment elevation at least two related leads) and increase and then decrease in cardiac biomarkers. Coronary artery disease is the leading cause of death and disability in the world and especially in western countries. In 2004, 9.4% (2.5 million) of deaths in low income countries and 16.3% (1.3 million) of deaths in high-income countries have constituted ischemic heart disease. Approximately 935,000 Americans suffer from an attack of myocardial infarction, of , JGPT. All Rights Reserved. 27

2 who one-third are suffering from acute STsegment elevation myocardial infarction. Despite the progress made, acute myocardial infarction is a major problem of public health that decreases the 15 years of individual s life, and imposes 165 billion dollars a year in America. Of myocardial infarction complications can be pointed out arrhythmias, heart failure, in farced heart septum rupture, blood clot on in farcted heart septum and cardiac autism that each has its own special significance and treatment [1]. Endocardium inflammation during acute phase myocardial infarction provides a thrombogenic level to create clot in left ventricular. It seems the incidence of ventricular thrombi following STEMI is reduced from 20% to 5%, followed by more aggressive use of anticoagulants [2]. Prospective studies have shown that patients with clot formation in the first 24 to 48 have very poor premature prognosis and high mortality due to MI complications. Although se ptal clot sticks to myocardial in farced surface of endocardium, the surface can be removed, leading to systemic arterial emboli. Although, estimates of its prevalence vary according to selected patients, but about 10 percent of se ptal clots will lead to systemic emboli. [3-5]. Based on previous experiments with limited sample size, it seems that the use of anticoagulants (intravenous or subcutaneous heparin with high-dose) reduces 50% of the progression of left ventricular emboli. Fibrinolysis reduces clot formation and the shape, so they are less swollen. However, detailed information about fibrinolytic tests is difficult due to interventional effect of anticoagulation with heparin.et al. [6] [3] Suggestions for anticoagulation treatment are markedly different and fibrinolysis results in the fatal emboli. However, anticoagulation therapy with warfare for 3 to 6 months is recommended for most patients with sepal clot. [7] Based on available data, our experience is the use of anticoagulation (intravenous heparin to increase PTT 1. 5 to 2 times normal, and the use of warfare for at least 3 to 6 months) in the following clinical situations: Embolic event occurs Patients with a large anterior infarction with or without the presence of visible in echocardiography We also want to use the same method of anticoagulation for patients with infarction, except in anterior area where have clots or severe sepal motion abnormalities. Although aspirin may not be able to influence the size of the clot, however, may prevent greater platelet deposition on the previous clot and also prevent further ischemia. Aspirin should be used in combination with warfarin for patients undergoing long-term anticoagulation therapy based on mentioned indications. Despite numerous studies in the area of medical sciences in clinical [8-11] and service fields [12] very little researches have been done in this area. However, anticoagulation therapy with warfare for 3 to 6 months is recommended for most patients with sepal clot [3]. Given that very few studies have been done in this area and even such study is not found in Iran, and given the lack of a regional survey that reflects the state of our society, this study was conducted not only to compare the current state of our society, but also based on knowledge gained planned for the prevention of disability in the society. Methods In the present analytical study a group of patients with diagnosis of myocardial infarction were enrolled, finally 100 patients, who were referred consecutively with myocardial infarction diagnosis since the start of plan to Se yyed-al-shohada Hospital, were selected. And factors affecting clot in the heart after myocardial infarction were reviewed, which include the presence of diabetes, smoking, hypertension, lipid disorders, age, gender, area affected in the heart, left ventricular diastolic dysfunction and restore blood flow in affected vessels and data were collected in , JGPT. All Rights Reserved. 28

3 a checklist that have been prepared from information of patient records. The patients were monitored on days 2 and 7 by me and fellowship echocardiography professors, in terms of in the left ventricle as well as other echocardiography parameters were evaluated including survey of area affected, size of the left ventricle, the left ventricular systolic dysfunction and diastolic dysfunction of the left ventricle and registered in the form and the effects of factors on the incidence of clot were assessed. Descriptive characteristics of patients are presented in frequency tables and graphs and in surveying the relationship between qualitative and quantitative variables with the occurrence of clots T-test and Chi-square tests were used. To perform these tests SPSS17 software is used. Results In this study 100 patients, who were referred consecutively with myocardial infarction diagnosis since the start of plan to Seyyed-alshohada Hospital, were selected. Of 100 patients studied, 79 patients (79%) were male and 21 patients (21%) were female. Their mean age was ± years, minimum 37 years and maximum 85 years. 63 patients were smokers and 37 were nonsmokers. Only 11 patients (11%) had consumed alcohol, and 38 patients had hypertension, and 62 patients had not hypertension. Diabetes mellitus was reported in 19 patients. And the history of CAD, 13 patients (13%) had positive CAD and 87 patients (87%) had negative CAD. Dyslipidemia in 34 patients (34%) were reported and in 66 patients (66%) were negative. 37 patients (37%) were received SK and 63 patients (63%) were not received SK. Primary PCI was performed in 45 patients (45%) and in 55 patients (55%) was not performed. was reported in 16 patients (16%) and in 84 (84%) left ventricular was not reported. Of 100 patients, in 54 patients (54%) MI was anterior and 46 patients (4%) MI was inferior. Table 1: Frequency distribution of demographic data in the study population Percentage 63% 37% 11% 89% 62% 38% 19% 81% 13% 87% 34% 66% 37% 63% Frequency Variable Smoke Non-smoke Alcohol Non-alcohol hypertension hypertension not Diabetes Non-diabetes Positive CAD Negative Dyslipidemia Non- dyslipidemia Received SK Not Received SK 45% 55% 16% 84% 54% 46% Primary PCI Primary PCI Non- With left ventricular Without left ventricular Anterior MI Inferior Surveying the relationship between sex and clot in the left ventricle, results showed that of 16 patients with left ventricular thrombi 14 patients (87.5%) were male and 2 patients (12.5) were female. Of 84 patients who had not left ventricular, 65 patients (77.4%) were male and 19 patients (22.6%) were female. According to statistical test there is no significant difference between patients with left ventricular thrombi and sex of the patients. (p=0.29) , JGPT. All Rights Reserved. 29

4 In surveying the relationship between clot in the left ventricle and underlying diabetes disease, of 16 patients with left ventricular thrombi 3 patients (18.8%) had diabetes, and 13 patients (81.3%) had not diabetes and of 84 patients who had not left ventricular, 16 patients (19%) had diabetes, and 68 patients (81%) had not diabetes. According to statistical test there is no left ventricular thrombi and underlying diabetes disease. (p=0.64) Table 2: Determination of the relationship between left ventricular and diabetes Diabetes (81.3%)13 (18.8%)3 (81%)68 (19%)16 (81%)81 (19%)19 (P=0.64) Of 16 patients with left ventricular thrombi there was no MI history and of 84 patients that had not left ventricular thrombi 9 patients (10.7%) had a history of previous MI and 75 patients (89.3%) had not a history of MI. According to statistical test there is no left ventricular thrombi and a history of previous MI. (p=0.19) dyslipidemia, 11 patients (68.8%) had not a history of dyslipidemia. Of 84 patients who had not left ventricular, 29 patients (34.5%) had a history of hyperlipidemia and 55 patients (65.5%) had not a history of dyslipidemia. According to statistical test there is no significant difference between patients with left ventricular thrombi and a history of hyperlipidemia. (p=0.55) Of 16 patients with left ventricular, 5 patients (31.3%) had a history of Table 3: Determination of the relationship between left ventricular and a history of hyperlipidemia (68.8%)11 (65.5%)55 (66%)66 (p=0.55) Of 16 patients with left ventricular 10 patients (62.5%) smoked and 6 patients (37.5%) did not smoke. Of 84 patients who had not left ventricular, 53 patients (63.1%) smoked, and 31 patients (36.9%) did not smoke. According to statistical test there is no significant difference between patients with left ventricular thrombi and smoking. (p=0.57) Dyslipidemia (31.3%)5 (34.5%)29 (34%)34 Of 16 patients with left ventricular, 5 patients (31.3%) were received SK and 11 patients (68.8%) were not received SK. Of 84 patients who had not left ventricular, 32 patients (38.1%) were received SK and 52 patients (61.9%) were not received SK. According to statistical test there is no significant difference between patients with left ventricular thrombi and receiving SK. (p=0.41) Table 4: Determination of the relationship between left ventricular and receiving SK (68.8%) (36%)63 (p=0.41) SK (31.3%)5 (38.1%)32 (37%)37 13 patients (81.3%) had anterior MI and , JGPT. All Rights Reserved. 30

5 patients (18.8%) had inferior MI. Of 84 patients who had not left ventricular 41 patients (48.8%) and anterior MI and 43 patients (51.2%) had inferior MI. According to statistical test there is no left ventricular thrombi and receiving MI. (p=0.01) Table 5: Determination of the relationship between left ventricular and MI MI Inferior Anterior (18.8%)3 (81.3%)13 (51.2%)43 (48.8%)41 (46%)46 (54%)54 (p=0.01) 6 patients (37.5%) received Primary PCI and 10 patients (62.5%) did not receive Primary PCI. Of 84 patients who had not left ventricular, 39 patients (46.4%) received Primary PCI and 45 patients (53.6%) did not received Primary PCI. According to statistical test there is no left ventricular thrombi and receiving Primary PCI. (p=0.35) Table 6: Determination of the relationship between left ventricular and receiving Primary PCI (62.5%)10 (53.6%)45 (55%)55 (p=0.35) Primary PCI (37.5%)6 (46.4%)39 (45%)45 81 patients (81%) have received SK or Primary PCI and 19 patients (19%) have not received SK or Primary PCI. 11 patients (68.8%) had received Primary PCI or SK and 5 patients (31.2%) had not received Primary PCI or SK. Of 84 patients who had not left ventricular, 70 patients (83.3%) had received Primary PCI or SK and 14 patients (16.7%) had not received SK or Primary PCI. According to statistical Fisher Exact test there is no significant difference between patients with left ventricular thrombi and receiving Primary PCI or SK. (p=0.15) Table 7: Determination of the relationship between left ventricular and receiving Primary PCI or SK SKor Primary PCI left ventricular (31.2%) (68.8%)11 (16.7%)14 (83.3%)70 (19%)19 (81%)81 (p=0.15) 4 patients (25%) had received Heparin or Enoxaparin and 12 patients (75%) had not received any of the two drugs. Of 84 patients who had not left ventricular, 65 patients (77.4%) had received Heparin or Enoxaparin and 19 patients (22.6%) had not received. According to statistical test there is a left ventricular thrombi and receiving Heparin and Enoxaparin. (p=0.001) , JGPT. All Rights Reserved. 31

6 Table 8: Determination of the relationship between left ventricular and receiving Heparin or Enoxaparin Not received (75%)12 (22.6)19 (31%)31 (p=0.001) 8 patients (50%) had received Met oral and 8 patients (50%) had not received. Of 84 patients who had not left ventricular, 66 patients (78.6%) had received HeparinorEnoxaparin Received (25%)4 (77.4%)65 (69%)69 Met oral and 18 patients (21.4%) had not received. According to statistical test there is a left ventricular thrombi and receiving Met oral. (p=0.02) Table 9: Determination of the relationship between left ventricular and receiving Met oral Not received (50%)8 (21.4%)18 (26%)26 (p=0.02) 12 patients (75%) had received captopril treatment, 4 patients (25%) had not received. Of 84 patients without left ventricular, 72 patients (85.7%) had received Met oral Received (50%)8 (78.6%)66 (74%)74 caporal, 12 patients (14.3%) had not received. According to statistical test there is no left ventricular thrombi and receiving caporal. (p=0.23) Table10: Determination of the relationship between left ventricular and receiving caporal Not received (25%)4 (14.3%)12 (16%)16 (p=0.023) Captopril Received (75%)12 (85.7%)72 (84%)84 Of 16 patients with left ventricular, 1 patient (6.2%) had AF, and 15 patients (93.8%) had not AF. Of 84 patients who had not left ventricular, 1 patient (1.2%) had AF, and 81 patients (98.8%) had not AF. According to statistical Table11: Determination of the relationship between left ventricular and AF test there is no significant difference between patients with left ventricular thrombi and AF. (p=0.30) (93.8)1 (98.8%)83 (98%)98 (p=0.30) AF (6.2%)1 (1.2%)1 (2%)2 Of 16 patients with left ventricular, 5 patients (31.2%) had involvement of 4 leads and 11 patients (68.8%) had more than 4 leads involved. Of 84 patients who had not left ventricular, 47 patients (56%) had less than or equal to 4 leads involvement, 37 patients (44%) had more than 4 leads involvement. According to statistical test there is no left ventricular thrombi and leads involved. (p=0.06) , JGPT. All Rights Reserved. 32

7 Table12: Determination of the relationship between left ventricular and leads involved <4 (68.8%)11 (44%)37 (48%)48 (p=0.06) 14 patients (87.5%) had LV enlargement, and in 2 patients (12.5%) LV was normal. Of 84 patients who had not left ventricular, 73 patients (86.9) had LV Involved lead 4 (31.2%)5 (56%)47 (52%)52 enlargement and in 11 patients (13.1%) LV was normal. According to statistical test there is no significant difference between patients with left ventricular thrombi and size of LV. (p=0.65) Table13: Determination of the relationship between left ventricular and size of LV Normal (12.5%)2 (13.1%)11 (13%)13 (p=0.65) Mean duration of pain to get to the hospital in patients with left ventricular thrombi was ± minutes and in patients without left ventricular was ± According to Log-Rang statistical test there is a significant difference between left ventricular thrombi and onset of pain to get to the hospital. (P=0.01) Mean duration to hospital arrival to onset of SK or PCI in patients with left ventricular thrombi was 341± minutes and in Sizzle Large (87.5%)14 (86.9%)73 (87%)87 patients without left ventricular were ±30.94 minutes. According to Log-Rang statistical test there is a significant difference between left ventricular thrombi and hospital arrival time to onset of SK or PCI. (P=0.02) Comparison of mean and standard deviation of increasing ST, MVDT, WMI, EF, CT ni with left ventricular thrombi is shown in the table below. Table 14: Comparison of mean and standard deviation of increasing ST, MVDT, WMI, EF, CT ni with left ventricular thrombi SD±Mean thrombi Variable Discussion 3 ± ± ± ± ± ± ± ± ± ±8.97 Myocardial infarction occurs following clot on a wound atherosclerotic plaque. These clots following a complete blockage of blood vessels increasingst MVDT WMI EF Ct ni prevent blood containing oxygen and nutrients to reach the tissues, the blocked blood vessels are responsible for blood supply to the area. In 2004, 9.4% (2.5 million) of deaths in low income countries and 16.3% (1.3 million) of deaths in high-income , JGPT. All Rights Reserved. 33

8 countries have constituted ischemic heart disease. Of myocardial infarction complications can be pointed out arrhythmias, heart failure, in farcted heart septum rupture, blood clot on in farcted heart septum and cardiac autism that each has its own special significance and treatment. [4] In this study, men were (79%) and women were (21%) of patients and there was no significant correlation between underlying diabetes disease, previous history of MI, history of hyperlipidemia, smoking and SK, but in our study there is a significant difference between type of MI and left ventricular clots. In the present study it was shown that there is no significant difference between primary PCI and the incidence of in the left ventricle so that of 16 patients with left ventricular thrombi, 11 patients (68.8%) had received primary PCI or SK, and 5 patients (31.2 %) had not received primary PCI or SK. Of 84 patients without clot into the left ventricle, 70 patients (83.3%) had received primary PCI or SK, and 14 patients (16.7%) had not received SK or primary PCI. According to statistical Fisher Exact test there is no significant difference between patients with left ventricular thrombi and receiving Primary PCI or SK. (p=0.15) The results showed that there is a significant difference between patients with left ventricular thrombi and receiving Heparin and Enoxaparin and also left ventricular thrombi and receiving Metoral but there is no left ventricular thrombi and leads involved. However, the mean time from pain onset to hospital arrival in patients with left ventricular thrombi was ± minutes and in patients without left ventricular were ± minutes. The mean time to hospital arrival to onset of SK or PCI in patients with left ventricular thrombi was 341± min and in patients without left ventricular was ±94.30 min. that shows a significant difference in terms of left ventricular and it can be noted that onset of pain and hospital arrival for receiving the first treatment step is an important factor in the development of clots within the left ventricle which can affect the outcome. Mean MVDT in 16 patients with clot into the left ventricle was, ±40.52 and in 84 patients without left ventricular was ± According to statistical t- test there is a significant difference between the thrombi in the left ventricle and MVDT. (P=0.006) Mean WMI in 16 patients with clot into the left ventricle was, 2.03±0.30 and in 84 patients without left ventricular was 1.66±0.33. According to statistical t-test there is a significant difference between the thrombi in the left ventricle and WMI. (P=0.0001) Mean EF in 16 patients with clot into the left ventricle was, 21.56±8.31 and in patients without left ventricular was 36.90±9.78. According to statistical t-test there is a significant difference between the thrombi in the left ventricle and LV size. (P=0.0001) Mean CT ni in 16 patients with clot into the left ventricle was, 24.68±13.98 and in patients without left ventricular was 17.10±8.97. According to statistical t-test there is a significant difference between the thrombi in the left ventricle and CT ni. (P=0.0001) In a study by Jacobs et al.[13] conducted on 10,383 patients with acute myocardial infarction, the use of ACE-I and beta-blockers was associated with a dramatic reduction in the risk of CVA. [13] Which shows the left ventricle is prevented from clogging. However, in our study, only the use of betablockers was significantly associated with a lower incidence of left ventricular. In a study by that was conducted on 70 patients with first anterior myocardial infarction attack, it was shown that the addition of low LVEF, lower MVDT and lower wall motion score index are also associated with left ventricular formation in patients with anterior myocardial infarction that the results are consistent with the results from our study , JGPT. All Rights Reserved. 34

9 In a case study that provided by Dantzig [3] on 2018 patients, almost exclusively left ventricular was occurred in patients with anterior myocardial infarction with a frequency of 39% compared with 0-5% in patients with non-anterior myocardial infarction. [3]In our study also of 16patients with left ventricular, 13 patients (81.3%) had anterior MI, and 3 patients (18.8%) had inferior MI that the above results are consistent with the results from our study. In a study by Zielinska M [5] in Poland on 2911 patients with acute anterior myocardial infarction that 2.5% of patients were with left ventricular thrombi. However, in our study the incidence of left ventricular thrombi was 16% of the patients with myocardial infarction regardless of MI type that seems cause of the high difference is due to this issue and also the presence of neglected MI, less use of anticoagulation in our study and the time of referral. In a study by Arshad Rehan[4], a total of 92 patients following acute STEMI with PCI and treated with inhibitors of glycoprotein IIb / IIIa, only 3.4% of patients had left ventricular that all patients involved were male. In the results of our study also, 5.87% of males were suffered severe left ventricular thrombi that were roughly consistent with the results of Arshad Rehan [4] In a study by Kontury F et al. in 1998 in Norway on 38 patients with acute anterior myocardial infarction, it was shown that in 53.6% of patients developed a clot in the left ventricular that was associated with severe impairment of wall motion in patients that is consistent with our results. In this study, left ventricular clots occurred following heart attack, even by administration of streptokinase that was the same as our study. In a study by in Massachusetts, of 75 patients with acute anterior myocardial infarction 46% had left ventricular. However, in our study the incidence of left ventricular was 16% of patients with myocardial infarction, regardless of the type of MI that seems this is the cause of much difference in the incidence of left ventricular. Also in this study, the incidence of in the left ventricle is increasing with heart wall motion disorders. Patients with left ventricular thrombi have usually much larger systolic and diastolic size than the others [2] which is consistent with the results obtained in our study. In this study comparing patients with and without thrombosis, had similar age and in both groups had similar rates of diabetes, history of myocardial infarction and dyslipidemia, which is consistent with the results obtained in our study. In this study also left ventricular is strongly associated with anterior acute myocardial infarction, EF less than 40% and hypertension. Patients who underwent PCI had a lower incidence of left ventricular. In our study also left ventricular thrombi is associated with acute anterior infarction, lower EF, but was not associated with high blood pressure and performing PCI. In our study also left ventricular thrombi is not associated with the type of received medicine. In a study by Vecchio [7] on 180 patients with first acute anterior myocardial infarction, it was concluded that the incidence of left ventricular thrombi is not different with streptokinase or Tpa treatment. Finally, given the relatively high frequency of in the left ventricle that is the manifestation of our society and given that typically in echocardiography that is performed following acute myocardial infarction a very low percentage of serious accidents are reported. This difference manifested the low sensitivity in the accuracy for detecting left ventricular that the final result of this study highlights the fact that there should be specific and non-specific features used for detecting left ventricular. In addition, to prevent effects of these lesions, we should be more accurate and more sensitive for detecting left ventricular in all patients referred with acute myocardial infarction. [14-16] , JGPT. All Rights Reserved. 35

10 References 1. Kontny F1, Dale J (1998) formation and resolution in acute myocardial infarction. Int J Cardiol, 66(2): Lamas GA, Vaughan DE, Pfeffer MA (1988) formation after first anterior wall acute myocardial infarction. Am J Cardiol,1; 62(1): J M van, Dantzig BJ, Delemarre H, Bot CA Visser (1996) in acute myocardial infarction, European Heart Journal 17: Arshad Rehan 1, ManpreetKanwar, Howard Rosman, Sujood Ahmed, Arshad Ali, Julius Gardin Gerald Cohen (2006) Incidence of post myocardial infarction left ventricular formation in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors. A prospective observational study. Cardiovascular Ultrasound,4:20 5. Zielinska M1, Kaczmarek K, Tylkowski M (2008) Predictors of left ventricular formation in acute myocardial infarction treated with successful primary angioplasty with stenting. Am J Med Sci. 335(3): Ertuğru lokuyan, Barış Okcun, Mustafa H, Dinçkal Haşim Mutlu (2010) Risk factors for development of left ventricular after first acute anterior myocardial infarction-association with anticardiolipin antibodies, Thrombosis Journal, 8:15 7. C Vecchio F, Chiarella G, Lupi P, Bellotti S Domenicucci (1991) in anterior acute myocardial infarction after thrombolysis. A GISSI-2 connected study. Circulation 84: Rahimi-Rad MH, Eishi A (2009) Superior vena cava syndrome in a man with situs inversustotalis and left main bronchus cancer. Pneumologia, 58(1): Valizadeh N, EishiOskuie A, Oni Heris, S (2014) Hydroxyurea induced longitudinal melanonychia: A picture presentation. Iranian Journal of Blood and Cancer. IJBC,7(1): Gheibi S, Mahmudloo R, Eishi-Oskuie A, Valizadeh N (2011) Multiple gastrointestinal stromal tumors (GISTs) of stomach in a healthy 13 year-old girl. International Journal of Hematology- Oncology and Stem Cell Research, 5(4): EishiOskuie A, Valizadeh N, Ilkhanizadeh BA (2010) case of type 1 Gaucher's disease associated with nonhodgkin lymphoma. Shiraz E Medical Journal,11(2): EishiOskuie A, Valizadeh N Acinar (2011) cell carcinoma of pancreas associated with plasma cell dyscrasia, a case report. Shiraz E Medical Journal. January, 12,(1): Jacob A, U dell, Julie T, Wang David J Gladstone, Jack V (2010) To Anticoagulation after Anterior Myocardial Infarction and the Risk of Stroke, Plosone August 5: Elliott M. Antman Braunwald s Text Book of Cardiology in CHAPTER 54 ST- Segment Elevation Myocardial Infarction: Pathology, Pathophysiology, and Clinical Features. Www. Bookfi.org 15. Hurst's the Heart, Chapter 60. In ST- Segment Elevation Myocardial Infarction, Www. Bookfi.org 16. Valizadeh N, Delpak A, EishiOskuie A, Valizadeh N (2015) Is there any association between thyroid autoimmunity and breast cancer?. Iranian Journal of Blood and Cancer. IJBC,7(4): , JGPT. All Rights Reserved. 36

Acute Myocardial Infarction

Acute Myocardial Infarction Acute Myocardial Infarction Hafeza Shaikh, DO, FACC, RPVI Lourdes Cardiology Services Asst.Program Director, Cardiology Fellowship Associate Professor, ROWAN-SOM Acute Myocardial Infarction Definition:

More information

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

Acute Myocardial Infarction. Willis E. Godin D.O., FACC Acute Myocardial Infarction Willis E. Godin D.O., FACC Acute Myocardial Infarction Definition: Decreased delivery of oxygen and nutrients to the myocardium Myocardial tissue necrosis causing irreparable

More information

OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION

OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION FEROZ MEMON*, LIAQUAT CHEEMA**, NAND LAL RATHI***, RAJ KUMAR***, NAZIR AHMED MEMON**** OBJECTIVE: To compare morbidity,

More information

LEFT VENTRICULAR THROMBUS IN ACUTE MYOCARDIAL INFARCTION

LEFT VENTRICULAR THROMBUS IN ACUTE MYOCARDIAL INFARCTION LEFT VENTRICULAR THROMBUS IN ACUTE MYOCARDIAL INFARCTION RATHI N 2, MAHESHWARI N 1, KUMARI D, SACHDEWANI RK, MEMON NA 2, MEMON F 3 ABSTRACT Objective: To determine Left ventricular thrombus (LVT) in acute

More information

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Seung-Jae Joo and other KAMIR-NIH investigators Department of Cardiology, Jeju National

More information

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA Dr Lincoff is an interventional cardiologist and the Vice Chairman for Research

More information

4. Which survey program does your facility use to get your program designated by the state?

4. Which survey program does your facility use to get your program designated by the state? STEMI SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and STEMI

More information

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in

More information

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João

More information

12 Lead EKG Chapter 4 Worksheet

12 Lead EKG Chapter 4 Worksheet Match the following using the word bank. 1. A form of arteriosclerosis in which the thickening and hardening of the vessels walls are caused by an accumulation of fatty deposits in the innermost lining

More information

Acute Coronary Syndromes

Acute Coronary Syndromes Overview Acute Coronary Syndromes Rabeea Aboufakher, MD, FACC, FSCAI Section Chief of Cardiology Altru Health System Grand Forks, ND Epidemiology Pathophysiology Clinical features and diagnosis STEMI management

More information

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors Lecture 8 Cardiovascular Health 1 Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors 1 Human Health: What s Killing Us? Health in America Health is the U.S Average life

More information

Abstract Background: Methods: Results: Conclusions:

Abstract Background: Methods: Results: Conclusions: Two-Year Clinical and Angiographic Outcomes of Overlapping Sirolimusversus Paclitaxel- Eluting Stents in the Treatment of Diffuse Long Coronary Lesions Kang-Yin Chen 1,2, Seung-Woon Rha 1, Yong-Jian Li

More information

MYOCARDIALINFARCTION. By: Kendra Fischer

MYOCARDIALINFARCTION. By: Kendra Fischer MYOCARDIALINFARCTION By: Kendra Fischer Outline Definition Epidemiology Clinical Aspects Treatment Effects of Exercise Exercise Testing Exercise Rx Summary and Conclusions References Break it down MYOCARDIAL

More information

CHAPTER-I MYOCARDIAL INFARCTION

CHAPTER-I MYOCARDIAL INFARCTION CHAPTER-I MYOCARDIAL INFARCTION Definition A myocardial infarction, more commonly known as MI or acute myocardial infarction (AMI) or heart attack is a condition where there is interruption of blood supply

More information

UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18

UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18 UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18 INTRODUCTION The clinical entities that comprise acute coronary syndromes (ACS)-ST-segment

More information

When the learner has completed this module, she/he will be able to:

When the learner has completed this module, she/he will be able to: Thrombolytics and Myocardial Infarction WWW.RN.ORG Reviewed September 2017, Expires September 2019 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2017

More information

QUT Digital Repository:

QUT Digital Repository: QUT Digital Repository: http://eprints.qut.edu.au/ This is the author s version of this journal article. Published as: Doggrell, Sheila (2010) New drugs for the treatment of coronary artery syndromes.

More information

ST-elevation myocardial infarctions (STEMIs)

ST-elevation myocardial infarctions (STEMIs) Guidelines for Treating STEMI: Case-Based Questions As many as 25% of eligible patients presenting with STEMI do not receive any form of reperfusion therapy. The ACC/AHA guidelines highlight steps to improve

More information

Management of Acute Myocardial Infarction

Management of Acute Myocardial Infarction Management of Acute Myocardial Infarction Prof. Hossam Kandil Professor of Cardiology Cairo University ST Elevation Acute Myocardial Infarction Aims Of Management Emergency care (Pre-hospital) Early care

More information

Objectives. Acute Coronary Syndromes; The Nuts and Bolts. Overview. Quick quiz.. How dose the plaque start?

Objectives. Acute Coronary Syndromes; The Nuts and Bolts. Overview. Quick quiz.. How dose the plaque start? Objectives Acute Coronary Syndromes; The Nuts and Bolts Michael P. Gulseth, Pharm. D., BCPS Pharmacotherapy II Spring 2006 Compare and contrast pathophysiology of unstable angina (UA), non-st segment elevation

More information

Korea University Guro Hospital, Seoul, Korea * Chonnam National University Hospital, Gwangju, Korea

Korea University Guro Hospital, Seoul, Korea * Chonnam National University Hospital, Gwangju, Korea Left Main Disease versus Non Left Main Disease in Acute Myocardial Infarction Patients in Real world Clinical Practice : Lessons from Korea Acute Myocardial Infarction Registry (KAMIR) Seung-Woon Rha*,

More information

Myocardial Infarction In Dr.Yahya Kiwan

Myocardial Infarction In Dr.Yahya Kiwan Myocardial Infarction In 2007 Dr.Yahya Kiwan New Definition Of Acute Myocardial Infarction The term of myocardial infarction should be used when there is evidence of myocardial necrosis in a clinical setting

More information

Diagnosis and Management of Acute Myocardial Infarction

Diagnosis and Management of Acute Myocardial Infarction Diagnosis and Management of Acute Myocardial Infarction Acute Myocardial Infarction (AMI) occurs as a result of prolonged myocardial ischemia Atherosclerosis leads to endothelial rupture or erosion that

More information

Quinn Capers, IV, MD

Quinn Capers, IV, MD Heart Attacks Mended Hearts Presentation, January, 2017 Quinn Capers, IV, MD Associate Professor of Medicine (Cardiovascular Medicine) Director, Transradial Coronary Interventions Division of Cardiovascular

More information

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI)

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI) Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for Artery, Atrial Fibrillation, Hypertension

More information

Cronicon CARDIOLOGY. N Laredj*, HM Ali Lahmar and L Hammou. Abstract

Cronicon CARDIOLOGY. N Laredj*, HM Ali Lahmar and L Hammou. Abstract Cronicon OPEN ACCESS CARDIOLOGY Research Article Persistent Ischemia in Recovery Predicts Mortality after Myocardial Infarction in Patients Undergoing Dobutamine N Laredj*, HM Ali Lahmar and L Hammou Department

More information

Acute Coronary syndrome

Acute Coronary syndrome Acute Coronary syndrome 7th Annual Pharmacotherapy Conference ACS Pathophysiology rupture or erosion of a vulnerable, lipidladen, atherosclerotic coronary plaque, resulting in exposure of circulating blood

More information

Early discharge in selected patients after an acute coronary syndrome can it be safe?

Early discharge in selected patients after an acute coronary syndrome can it be safe? Early discharge in selected patients after an acute coronary syndrome can it be safe? Glória Abreu, Pedro Azevedo, Carina Arantes, Catarina Quina-Rodrigues, Sara Fonseca, Juliana Martins, Catarina Vieira,

More information

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor Lecture 9 Cardiovascular Health 1 Lecture 9 1. Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor 1 The Heart Muscular Pump The Heart Receives blood low pressure then increases the pressure

More information

1. Diabetes mellitus (DM) is associated with worse clinical and angiographic outcomes even in acute myocardial Infarction (AMI) patients.

1. Diabetes mellitus (DM) is associated with worse clinical and angiographic outcomes even in acute myocardial Infarction (AMI) patients. Midterm Clinical Outcomes of Insulin Requiring Diabetes Mellitus versus Non-insulin Dependent Diabetes Mellitus in Acute Myocardial Infarction Patients in Drug Eluting Stent Era : Insight from Korea Acute

More information

Supplementary Material to Mayer et al. A comparative cohort study on personalised

Supplementary Material to Mayer et al. A comparative cohort study on personalised Suppl. Table : Baseline characteristics of the patients. Characteristic Modified cohort Non-modified cohort P value (n=00) Age years 68. ±. 69.5 ±. 0. Female sex no. (%) 60 (0.0) 88 (.7) 0.0 Body Mass

More information

Role of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University

Role of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University Role of Clopidogrel in Acute Coronary Syndromes Hossam Kandil,, MD Professor of Cardiology Cairo University ACS Treatment Strategies Reperfusion/Revascularization Therapy Thrombolysis PCI (with/ without

More information

Continuing Medical Education Post-Test

Continuing Medical Education Post-Test Continuing Medical Education Post-Test Based on the information presented in this monograph, please choose one correct response for each of the following questions or statements. Record your answers on

More information

The PAIN Pathway for the Management of Acute Coronary Syndrome

The PAIN Pathway for the Management of Acute Coronary Syndrome 2 The PAIN Pathway for the Management of Acute Coronary Syndrome Eyal Herzog, Emad Aziz, and Mun K. Hong Acute coronary syndrome (ACS) subsumes a spectrum of clinical entities, ranging from unstable angina

More information

Objectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2

Objectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2 10/2013 1 Objectives Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2 Purpose of this Education Module: Chest Pain Center Accreditation involves

More information

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist physician Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Outcome objectives of the discussion: At the end of the

More information

FastTest. You ve read the book now test yourself

FastTest. You ve read the book now test yourself FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. The answers will refer you back to

More information

Comparison of Mean Platelet Volume in Acute Myocardial Infarction vs. Normal Coronary Angiography

Comparison of Mean Platelet Volume in Acute Myocardial Infarction vs. Normal Coronary Angiography Global Journal of Health Science; Vol. 8, No. 11; 2016 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education Comparison of Mean Platelet Volume in Acute Myocardial Infarction

More information

Simultaneous Acute ST Elevation Myocardial Infarction And Acute Left Subclavian Artery Thrombosis

Simultaneous Acute ST Elevation Myocardial Infarction And Acute Left Subclavian Artery Thrombosis Simultaneous Acute ST Elevation Myocardial Infarction And Acute Left Subclavian Artery Thrombosis Chee Yang CHIN, MBChB, MRCP(UK) C.W.L. Chin, P.T.L. Chiam, R.S. Tan National Heart Centre Singapore 26

More information

APPENDIX F: CASE REPORT FORM

APPENDIX F: CASE REPORT FORM APPENDIX F: CASE REPORT FORM Instruction: Complete this form to notify all ACS admissions at your centre to National Cardiovascular Disease Registry. Where check boxes are provided, check ( ) one or more

More information

Cardiovascular Disease

Cardiovascular Disease Cardiovascular Disease Chapter 15 Introduction Cardiovascular disease (CVD) is the leading cause of death in the U.S. One American dies from CVD every 33 seconds Nearly half of all Americans will die from

More information

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell

More information

Managing Quality of ACS Care in VHA The IDH Guideline Key Points and Metrics

Managing Quality of ACS Care in VHA The IDH Guideline Key Points and Metrics Managing Quality of ACS Care in VHA The IDH Guideline Key Points and Metrics Robert L. Jesse, MD, PhD National Program Director for Cardiology Veterans Health Administration Washington, DC Chief, Cardiology

More information

Thrombolytic effect of streptokinase infusion assessed by ST-segment resolution between diabetic and non-diabetic myocardial infarction patients

Thrombolytic effect of streptokinase infusion assessed by ST-segment resolution between diabetic and non-diabetic myocardial infarction patients ORIGINAL ARTICLE Cardiology Journal 2012, Vol. 19, No. 2, pp. 168 173 10.5603/CJ.2012.0029 Copyright 2012 Via Medica ISSN 1897 5593 Thrombolytic effect of streptokinase infusion assessed by ST-segment

More information

Cardiovascular Diseases and Diabetes

Cardiovascular Diseases and Diabetes Cardiovascular Diseases and Diabetes LEARNING OBJECTIVES Ø Identify the components of the cardiovascular system and the various types of cardiovascular disease Ø Discuss ways of promoting cardiovascular

More information

PRIMARY CORONARY ANGIOPLASTY VERSUS INTRAVENOUS THROMBOLYSIS FOR ACUTE MYOCARDIAL INFARCTION - A COMPARATIVE STUDY AT QUEEN ALIA HEART INSTITUTE

PRIMARY CORONARY ANGIOPLASTY VERSUS INTRAVENOUS THROMBOLYSIS FOR ACUTE MYOCARDIAL INFARCTION - A COMPARATIVE STUDY AT QUEEN ALIA HEART INSTITUTE PRIMARY CORONARY ANGIOPLASTY VERSUS INTRAVENOUS THROMBOLYSIS FOR ACUTE MYOCARDIAL INFARCTION - A COMPARATIVE STUDY AT QUEEN ALIA HEART INSTITUTE Walid Sawalha MD, MBBS (Lond), MRCP(UK)* ABSTRACT Objectives:

More information

Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI

Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI Dr Sasha Koul, MD Dept of Cardiology, Lund University Hospital, Lund, Sweden

More information

Cover Page. The handle holds various files of this Leiden University dissertation

Cover Page. The handle  holds various files of this Leiden University dissertation Cover Page The handle http://hdl.handle.net/1887/21543 holds various files of this Leiden University dissertation Author: Dharma, Surya Title: Perspectives in the treatment of cardiovascular disease :

More information

Acute Coronary Syndrome. Emergency Department Updated Jan. 2017

Acute Coronary Syndrome. Emergency Department Updated Jan. 2017 Acute Coronary Syndrome Emergency Department Updated Jan. 2017 Goals and Objectives To reduce mortality and morbidity for people who have cardiovascular disease, with a focus on those who experience an

More information

Ventricular Arrhythmias in Acute MI Patients Undergoing Primary PCI

Ventricular Arrhythmias in Acute MI Patients Undergoing Primary PCI Ventricular Arrhythmias in Acute MI Patients Undergoing Primary PCI Bulent Gorenek MD FACC FESC Eskişehir Osmangazi University Cardiology Department Eskisehir-Turkey I do not have any potential conflict

More information

Coronary Artery Calcium Score

Coronary Artery Calcium Score Coronary Artery Calcium Score August 19, 2014 by Axel F. Sigurdsson MD 174 Comments essential for living organisms. Calcium is a chemical element that is Most of the calcium within the human body is found

More information

Acute coronary syndromes

Acute coronary syndromes Acute coronary syndromes 1 Acute coronary syndromes Acute coronary syndromes results primarily from diminished myocardial blood flow secondary to an occlusive or partially occlusive coronary artery thrombus.

More information

The Cardiovascular System Part I: Heart Outline of class lecture After studying part I of this chapter you should be able to:

The Cardiovascular System Part I: Heart Outline of class lecture After studying part I of this chapter you should be able to: The Cardiovascular System Part I: Heart Outline of class lecture After studying part I of this chapter you should be able to: 1. Describe the functions of the heart 2. Describe the location of the heart,

More information

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply. WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:

More information

THE INCIDENCE OF PECTORIS ANGINA POST-ACUTE MYOCARDIAL INFARCTION IN ROMANIA RO-STEMI DATABASE

THE INCIDENCE OF PECTORIS ANGINA POST-ACUTE MYOCARDIAL INFARCTION IN ROMANIA RO-STEMI DATABASE THE INCIDENCE OF PECTORIS ANGINA POST-ACUTE MYOCARDIAL INFARCTION IN ROMANIA RO-STEMI DATABASE Catalina Liliana CALIN PhD, Associate Professor University of Medicine and Pharmacy Carol Davila, Bucharest,

More information

Acute Coronary Syndrome. Sonny Achtchi, DO

Acute Coronary Syndrome. Sonny Achtchi, DO Acute Coronary Syndrome Sonny Achtchi, DO Objectives Understand evidence based and practice based treatments for stabilization and initial management of ACS Become familiar with ACS risk stratification

More information

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018 Management of Stable Ischemic Heart Disease Vinay Madan MD February 10, 2018 1 Disclosure No financial disclosure. 2 Overview of SIHD Diagnosis Outline of talk Functional vs. Anatomic assessment Management

More information

Continuing Medical Education Post-Test

Continuing Medical Education Post-Test Continuing Medical Education Post-Test Based on the information presented in this monograph, please choose one correct response for each of the following questions or statements. Record your answers on

More information

STEMI 2014 YAHYA KIWAN. Consultant Cardiologist Head Of Cardiology Belhoul Specialty Hospital

STEMI 2014 YAHYA KIWAN. Consultant Cardiologist Head Of Cardiology Belhoul Specialty Hospital STEMI 2014 YAHYA KIWAN Consultant Cardiologist Head Of Cardiology Belhoul Specialty Hospital Aspiration Thrombectomy Manual aspiration thrombectomy is reasonable for patients undergoing primary PCI. I

More information

Quality Data on Core Measures

Quality Data on Core Measures Quality Data on Core Measures The Centers for Medicare and Medicaid (CMS) have developed several measurements to reflect the quality of care in hospitals. They include pneumonia, surgical care, heart failure

More information

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017 Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017 Trends of acute myocardial infarction in Korea from the experience of Korea Acute

More information

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Acute Coronary Syndrome Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Topics Timing is everything So many drugs to choose from What s a MINOCA? 2 Acute

More information

Appendix: ACC/AHA and ESC practice guidelines

Appendix: ACC/AHA and ESC practice guidelines Appendix: ACC/AHA and ESC practice guidelines Definitions for guideline recommendations and level of evidence Recommendation Class I Class IIa Class IIb Class III Level of evidence Level A Level B Level

More information

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? Keun-Ho Park, Myung Ho Jeong, Min Goo Lee, Jum Suk Ko,

More information

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI Gamal Abdelhady, Emad Mahmoud Department of interventional

More information

Objectives. Treatment of ACS. Early Invasive Strategy. UA/NSTEMI General Concepts. UA/NSTEMI Initial Therapy/Antithrombotic

Objectives. Treatment of ACS. Early Invasive Strategy. UA/NSTEMI General Concepts. UA/NSTEMI Initial Therapy/Antithrombotic Objectives Treatment of ACS Michael P. Gulseth, Pharm. D., BCPS Pharmacotherapy II Spring 2006 Define early invasive strategy and what patients typically receive this approach Compare/contrast the medications

More information

Fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Accelerated versus standard Streptokinase infusion regimen

Fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Accelerated versus standard Streptokinase infusion regimen J Cardiovasc Thorac Res, 217, 9(4), 29-214 doi: 1.15171/jcvtr.217.36 http://jcvtr.tbzmed.ac.ir TUOMS Publishing Group Original Article Fibrinolytic therapy in patients with ST-segment elevation myocardial

More information

Acute Coronary Syndrome

Acute Coronary Syndrome Acute Coronary Syndrome Clinical Manifestation of CAD Silent Ischemia/asymptomatic Stable Angina Acute Coronary Syndrome (Non- STEMI/UA and STEMI) Arrhythmias Heart Failure Sudden Death Pain patterns with

More information

Tailoring adjunctive antithrombotic therapy to reperfusion strategy in STEMI

Tailoring adjunctive antithrombotic therapy to reperfusion strategy in STEMI Tailoring adjunctive antithrombotic therapy to reperfusion strategy in STEMI Adel El-Etriby; MD Professor of Cardiology Ain Shams University President of the Egyptian Working Group of Interventional Cardiology

More information

Role of Early 2D Echocardiography in Patient with Acute Myocardial Infarction in Correlation with Electrocardiography and Clinical Presentation

Role of Early 2D Echocardiography in Patient with Acute Myocardial Infarction in Correlation with Electrocardiography and Clinical Presentation MVP Journal of Medical Sciences, Vol 1(2), 51 55, July 2014 Role of Early 2D Echocardiography in Patient with Acute Myocardial Infarction in Correlation with Electrocardiography and Clinical Presentation

More information

Pharmacologic Therapy of Coronary Disease

Pharmacologic Therapy of Coronary Disease Pharmacologic Therapy of Coronary Disease M. MOHSEN IBRAHIM, MD Prof. of Cardiology- Cairo University President of the Egyptian Hypertension Society Introduction Coronary artery disease (CAD) is possibly

More information

Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial

Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial compared with clopidogrel in patients with acute coronary syndromes the PLATO trial August 30, 2009 at 08.00 CET PLATO background In NSTE-ACS and STEMI, current guidelines recommend 12 months aspirin and

More information

DISCUSSION QUESTION - 1

DISCUSSION QUESTION - 1 CASE PRESENTATION 87 year old male No past history of diabetes, HTN, dyslipidemia or smoking Very active Medications: omeprazole for heart burn Admitted because of increasing retrosternal chest pressure

More information

ST-segment Elevation Myocardial Infarction (STEMI): Optimal Antiplatelet and Anti-thrombotic Therapy in the Emergency Department

ST-segment Elevation Myocardial Infarction (STEMI): Optimal Antiplatelet and Anti-thrombotic Therapy in the Emergency Department ST-segment Elevation Myocardial Infarction (STEMI): Optimal Antiplatelet and Anti-thrombotic Therapy in the Emergency Department decision-making. They have become the cornerstone of many ED protocols for

More information

Elements for a public summary. VI.2.1 Overview of disease epidemiology

Elements for a public summary. VI.2.1 Overview of disease epidemiology VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology Coronary artery disease and as anticoagulant (inhibiting the clotting of the blood) in patients undergoing surgery to treat blockages

More information

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Enrico Ferrari, MD Cardiac Surgery Unit Cardiocentro Ticino Foundation Lugano, Switzerland Conflict of Interests No conflict

More information

Management of Patients with Atrial Fibrillation Undergoing Coronary Artery Stenting 경북대의전원내과조용근

Management of Patients with Atrial Fibrillation Undergoing Coronary Artery Stenting 경북대의전원내과조용근 Management of Patients with Atrial Fibrillation Undergoing Coronary Artery Stenting 경북대의전원내과조용근 Case (2011, 5) 74-years old gentleman Exertional chest pain Warfarin with good INR control Ex-smoker, social(?)

More information

Controversies in Cardiac Pharmacology

Controversies in Cardiac Pharmacology Controversies in Cardiac Pharmacology Thomas D. Conley, MD FACC FSCAI Disclosures I have no relevant relationships with commercial interests to disclose. 1 Doc, do I really need to take all these medicines?

More information

Statistical analysis plan

Statistical analysis plan Statistical analysis plan Prepared and approved for the BIOMArCS 2 glucose trial by Prof. Dr. Eric Boersma Dr. Victor Umans Dr. Jan Hein Cornel Maarten de Mulder Statistical analysis plan - BIOMArCS 2

More information

Coronary Interventions Indications, Treatment Options and Outcomes

Coronary Interventions Indications, Treatment Options and Outcomes Coronary Interventions Indications, Treatment Options and Outcomes A talk should be like a woman s skirt long enough to cover the subject, but short enough to keep it interesting. Coronary anatomy Physiology

More information

ORIGINAL ARTICLE. Rescue PCI Versus a Conservative Approach for Failed Fibrinolysis in Patients with STEMI

ORIGINAL ARTICLE. Rescue PCI Versus a Conservative Approach for Failed Fibrinolysis in Patients with STEMI Heart Mirror Journal From Affiliated Egyptian Universities and Cardiology Centers Vol. 6, No. 3, 2012 ISSN 1687-6652 ORIGINAL ARTICLE for Failed Fibrinolysis in Patients with STEMI Mohamed Salem, MD, PhD;

More information

Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach

Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach Frans Van de Werf, MD, PhD University Hospitals, Leuven, Belgium Frans Van de Werf: Disclosures Research grants

More information

(For items 1-12, each question specifies mark one or mark all that apply.)

(For items 1-12, each question specifies mark one or mark all that apply.) Form 121 - Report of Cardiovascular Outcome Ver. 9.2 COMMENTS -Affix label here- Member ID: - - To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: - Central Case No.:

More information

VENOUS THROMBOEMBOLISM AND CORONARY ARTERY DISEASE: IS THERE A LINK?

VENOUS THROMBOEMBOLISM AND CORONARY ARTERY DISEASE: IS THERE A LINK? VENOUS THROMBOEMBOLISM AND CORONARY ARTERY DISEASE: IS THERE A LINK? Ayman El-Menyar (1), MD, Hassan Al-Thani (2),MD (1)Clinical Research Consultant, (2) Head of Vascular Surgery, Hamad General Hospital

More information

Chapter 4: Cardiovascular Disease in Patients with CKD

Chapter 4: Cardiovascular Disease in Patients with CKD Chapter 4: Cardiovascular Disease in Patients with CKD The prevalence of cardiovascular disease (CVD) was 65.8% among patients aged 66 and older who had chronic kidney disease (CKD), compared to 31.9%

More information

Timing of Surgery After Percutaneous Coronary Intervention

Timing of Surgery After Percutaneous Coronary Intervention Timing of Surgery After Percutaneous Coronary Intervention Deepak Talreja, MD, FACC Bayview/EVMS/Sentara Outline/Highlights Timing of elective surgery What to do with medications Stopping anti-platelet

More information

Acute coronary syndromes (ACS), including unstable

Acute coronary syndromes (ACS), including unstable n report n Acute Coronary Syndromes: Morbidity, Mortality, and Pharmacoeconomic Burden Daniel M. Kolansky, MD Abstract Acute coronary syndromes (ACS), which include unstable angina and myocardial infarction

More information

BEDSIDE ASSESSMENT OF PATIENTS WITH STEMI

BEDSIDE ASSESSMENT OF PATIENTS WITH STEMI BEDSIDE ASSESSMENT OF PATIENTS WITH STEMI Prof. Maria Dorobantu, PhD, FESC, FACC Emergency Hospital of Bucharest, Romania Presenter Disclosures There are no conflicts/ grants/ disclosures for this presentation.

More information

PROMUS Element Experience In AMC

PROMUS Element Experience In AMC Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical

More information

Calcium is a chemical element that is essential for living organisms.

Calcium is a chemical element that is essential for living organisms. 1 of 8 9/28/2015 9:04 AM Home About me Health and Nutrition Diet General Health Heart Disease August 19, 2014 By Axel F. Sigurdsson MD 259 Comments Like Share 82 Calcium is a chemical element that is essential

More information

Common Codes for ICD-10

Common Codes for ICD-10 Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified

More information

2008, American Heart Association. All rights reserved.

2008, American Heart Association. All rights reserved. AHA 2008 Cocaine-Associated Chest Pain and Myocardial Infarction Slide Set Based on the AHA 2008 Scientific Statement for Management of Cocaine-Associated Chest Pain and Myocardial Infarction George J.

More information

JMSCR Vol 04 Issue 03 Page March 2016

JMSCR Vol 04 Issue 03 Page March 2016 www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 5.88 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: http://dx.doi.org/10.18535/jmscr/v4i3.45 A Comparative Study of Clinical Outcome

More information

Heart Disease (Coronary Artery Disease)

Heart Disease (Coronary Artery Disease) Heart Disease (Coronary Artery Disease) Understanding how the heart works To understand heart disease, you must first know how the heart works. The heart is like any other muscle, requiring blood to supply

More information

FACTOR Xa AND PAR-1 BLOCKER : ATLAS-2, APPRAISE-2 & TRACER TRIALS

FACTOR Xa AND PAR-1 BLOCKER : ATLAS-2, APPRAISE-2 & TRACER TRIALS New Horizons In Atherothrombosis Treatment 2012 순환기춘계학술대회 FACTOR Xa AND PAR-1 BLOCKER : ATLAS-2, APPRAISE-2 & TRACER TRIALS Division of Cardiology, Jeonbuk National University Medical School Jei Keon Chae,

More information

Acute coronary syndrome (ACS) is an

Acute coronary syndrome (ACS) is an OVERVIEW OF MEDICAL MANAGEMENT OF ACUTE CORONARY SYNDROMES Robert B. Parker, PharmD * Acute coronary syndrome (ACS) is an umbrella term used to describe any group of symptoms of acute myocardial ischemia

More information

AP2 Lab 3 Coronary Vessels, Valves, Sounds, and Dissection

AP2 Lab 3 Coronary Vessels, Valves, Sounds, and Dissection AP2 Lab 3 Coronary Vessels, Valves, Sounds, and Dissection Project 1 - BLOOD Supply to the Myocardium (Figs. 18.5 &18.10) The myocardium is not nourished by the blood while it is being pumped through the

More information

Chest pain and troponins on the acute take. J N Townend Queen Elizabeth Hospital Birmingham

Chest pain and troponins on the acute take. J N Townend Queen Elizabeth Hospital Birmingham Chest pain and troponins on the acute take J N Townend Queen Elizabeth Hospital Birmingham 3 rd Universal Definition of Myocardial Infarction Type 1: Spontaneous MI related to atherosclerotic plaque rupture

More information

Is it safe to discharge patients 24 hours after uncomplicated successful primary percutaneous coronary intervention

Is it safe to discharge patients 24 hours after uncomplicated successful primary percutaneous coronary intervention Is it safe to discharge patients 24 hours after uncomplicated successful primary percutaneous coronary intervention DA Jones, J Howard, S Gallagher, KS Rathod, A Jain, S Mohiddin, C Knight, A Mathur, EJ

More information